Elon's Greatest Invention... Hidden in South Memphis?

In South Memphis, I uncovered what could be Elon Musk's biggest invention yet. It's so secretive, rivals are flying drones to spy on it. If you're serious about investing in AI, now's the time to see what's really going on inside those walls.

Meet Amy Gleason, the DOGE administrator who may - or may not - be wielding extraordinary power

RYAN J. FOLEY and BRIAN SLODYSKO
March 08, 2025

When her daughter was diagnosed with a rare autoimmune disease in 2010, Amy Gleason attacked the challenge.

She carried binders of medical records to doctors' appointments across six health systems seeking the best care for juvenile dermatomyositis. She volunteered at a nonprofit searching for a cure. She also started a health care company to create record-sharing software that would make life easier for chronically ill patients and families.

Within five years, President Barack Obama's White House recognized Gleason as a "Champion of Change" in the industry. When the coronavirus struck in 2020, she was a health care technologist in the first Trump White House who worked grueling hours building data systems to guide the federal response. (And her daughter was a thriving college student.)

Now, her journey has improbably led to President Donald Trump naming her the acting administrator of the U.S. DOGE Service, a position that seems to convey extraordinary power. Except almost no one has heard of her and everyone knows the man the president says is actually leading the unparalleled effort to gut the federal workforce and shutter agencies: Elon Musk.

Gleason's role at DOGE is unclear

While Musk has claimed his Department of Government Efficiency is fully transparent, until last week the White House press secretary would not even say Gleason's name -- which does not appear on the DOGE website.

In his address to Congress Tuesday, Trump made clear that Musk is in charge, saluting him as the head of DOGE, with Musk smiling down on the president from the visitors' gallery. Yet government lawyers have argued in court that Gleason and not Musk is the agency's leader.

The confusion has added to the mystery around the role of Gleason, who did not respond to a phone call or text message for comment.

"I don't think anyone really knows for sure what her role is and whether she actually has any oversight of any of the people doing the work, or is she just there as a punching bag and a distraction to keep their actual activities shielded from the public," said Brett Hartl, government affairs director for the Center for Biological Diversity, an environmental group that sued the DOGE Service and Gleason seeking access to records that would shed light on their operations.

DOGE claims credit for saving more than $100 billion through mass firings, cancellations of contracts and grants, office closures and other cuts that have paralyzed entire agencies. Many of those claimed savings have turned out to be overstated or unproven.

Gleason is known as a behind-the-scenes operator

On one level, Gleason fits the mold of a Musk employee, one willing to work arduous hours to meet his goals. Former colleagues say she is an effective behind-the-scenes operator and say her rise is the story of a former nurse who got into health care technology to help patients and doctors and climbed through merit.

"From my perspective, I can't imagine somebody I'd rather have there," said Jamie Grant, a former Republican lawmaker in Florida who worked with Gleason to start a health care company. "Somebody saying yes to that job right now better believe in the mission and better have a spine and be talented and she's that in spades."

White House press secretary Karoline Leavitt told reporters that Gleason had served as the acting administrator at DOGE for weeks. But that was not the widely held understanding of her position internally, according to three people with knowledge of the office's operation who spoke on condition of anonymity out of fear of retribution.

While the exact nature of Gleason's portfolio was not well defined, what was clear is that she was working closely with DOGE leaders. She attempted to push civil service staffers in the office to hire at least two people who failed screening reviews for prospective hires; both were later hired by DOGE, according to two of the people who spoke to The Associated Press.

The uncertainty over her role -- and when she was appointed to it -- could have far-reaching implications in a series of ongoing lawsuits filed to blunt the impact of Musk's radical paring of the government workforce.

Under questioning from U.S. District Court Judge Colleen Kollar-Kotelly recently, government attorneys struggled to explain who was in charge of DOGE or Musk's precise role. That led Kollar-Kotelly to wonder if the office was running afoul of the Constitution's appointments clause because Musk had not been nominated to lead the office, or received confirmation from the Senate.

The Trump administration announced the following day that Gleason was DOGE's acting administrator, a question they had previously refused to answer.

Gleason has ties to Trump world

Unlike many DOGE workers, Gleason has no prior ties to Musk. She recently worked as chief products officer at Nashville-based health care firms founded by Brad Smith, who worked in the prior Trump administration on health care and is also a DOGE adviser.

Smith and Gleason began working on Trump's transition after the November election, and her role in Trump's orbit has grown. In December, she rejoined the United States Digital Service, where she had previously worked from 2018 through 2021 on high-level government health care technology initiatives.

On his first day back in office, Trump signed an executive order rebranding USDS as the US DOGE Service and giving it a mandate to help Musk's cost-cutting initiative. Soon, dozens of Musk acolytes associated with DOGE began arriving at agencies across the government demanding access to sensitive data systems and pushing for drastic changes.

While 21 others in the office resigned in protest rather than carry out Musk's initiatives, Gleason accepted a position that thrust her into an unfamiliar spotlight.

Health care entrepreneur Travis Bond, Gleason's colleague over two decades at companies in Florida, said Gleason will hate the public attention but excel in her new role.

"I'm not sure they could have picked a better person. She just thinks, eats and breathes this stuff," he said.

Gleason helped build CareSync, which later collapsed

Bond, Gleason and Grant in 2011 launched CareSync Inc., which developed an app to allow patients suffering from chronic disease to keep their medical records in one place. After benefiting from a $7.25 million grant from one Florida county, CareSync found it hard to attract buyers for subscriptions that cost up to $199 annually.

CareSync pivoted in 2015, taking advantage of a new federal rule that allowed Medicare providers to bill for chronic care management services delivered remotely. The company raised millions of dollars from investors and began rapidly adding staff and serving more than 20,000 patients nationwide. By summer 2018, CareSync ran out of cash and closed without notice, firing 300 workers and leaving creditors owed millions.

Gleason recalled later that she was "trying to figure out what in the world to do in life" after that experience and applied for the USDS with encouragement from Aneesh Chopra, U.S. chief technology officer under Obama. Chopra declined comment.

She focused on improving technology systems at the Centers for Disease Control and Prevention and the Centers for Medicare and Medicaid Services. During the pandemic, she worked under White House response coordinator Dr. Deborah Birx to develop laboratory and hospital data reporting systems. Birx praised Gleason last week in an interview with CNN as a "really competent, hardworking, focused woman who understands the value of data."

Near the end of her three-year stint in 2021, Gleason reflected on her work in a podcast interview, saying the digital service sought to "empower the civil servants and to bring new approaches in technology to the government and to help modernize their efforts."

"Our mission is really to do the greatest good, for the greatest number of people, in the greatest need," she said.

Continue Reading...

Popular

Trump keeps saying the GOP mega bill will eliminate taxes on Social Security. It does not

WASHINGTON (AP) — President keeps saying that Republicans' mega legislation will eliminate taxes on federal benefits.

Back This Medical AI Tech - Ad

You don't often find healthcare tech company valued at $4M. HeartSciences is an exception. With $75M invested, including R&D, clinical trials, and product development, their patented AI software is approaching FDA submission, a potential major inflection point.

BigBear.ai, AMD, QuantumScape, Coinbase, Tesla: Why These 5 Stocks Are On Investors' Radars Today

U.S. stocks ended the day on a high note, with the Nasdaq gaining over 1.4% on Tuesday to 19,912.53. The Dow also traded up 1.2% to 43,089.02, while the S&P 500 rose by 1.1% to 6,092.18. These are the top stocks that gained the attention of retail traders and investors throughout the day:

These are the celebs who are attending Jeff Bezos’ Venice wedding

VENICE, Italy (AP) — arrived in Venice on Thursday, leading a star-studded guest list of celebrities descending on the lagoon city for the weekend wedding of Amazon founder Jeff Bezos and Lauren Sánchez.

A 64% Dividend From Gold? - Ad

Gold is soaring. But here's what no one's talking about: a way to earn a 64% dividend-paid in real cash every 30 days. No trading. No risky mining stocks. Just one simple move in your brokerage account... and you could start collecting monthly income almost instantly.

Datadog Stock Surges On S&P 500 Inclusion

Datadog Inc (NASDAQ:DDOG) shares are trading higher in Wednesday's after-hours session after it was announced that the company will join the S&P 500.

20 Surprising Reddit Facts To Celebrate Its Milestone Birthday

Here's a look at Reddit's best-kept secrets and odd historical footnotes as the platform turns 20.

FDA Submission Expected This Summer - Invest Before It Happens - Ad

This company is making heart disease easier to detect with AI. Their tech has officially been designated a "Breakthrough" by the FDA. You now have an opportunity to get in at a potential inflection point.

Why Are Central Banks Still Stockpiling Gold?

Central banks continue to increase gold reserves, viewing it as a tool to navigate global uncertainty. Confidence in gold remains strong.

Stunning Trump Policy Unlocks Upfront Cash Payouts - Ad

The U.S. has collected $15B from Trump's tariffs - and now, thanks to Title 15, you could claim your own $100-$1,000 instant upfront cash payouts. No stocks needed. Use your phone and this income technique to collect upfront payouts now.

Cramer Praises Monster Beverage As 'Smoking Hot,' Warns Investors About This AI Stock

Cramer recommends buying Okta (OKTA) as it reported strong earnings, but not to trust Nebius Group (NBIS), while Sweetgreen (SG) and Monster Beverage (MNST) have mixed views. He also suggests buying McDonald's (MCD) while their partnership with Krispy Kreme (DNUT) will end in 2025.

Do These 4 Things to Your Bank Account Now ... - Ad

A sweeping U.S. policy could soon let the government track-or even freeze-your bank account. But there are 4 simple steps you can take right now to protect your savings before it's potentially too late.

Mark Cuban Raises Employee Wages After Learning Of Government Aid Dependence

Mark Cuban, owner of the NBA's Dallas Mavericks, expressed his dismay upon learning that some of his employees were reliant on government aid programs.

Asia Markets Mixed, Europe Slips, Dollar Weakens Further As Tariff Deadline Looms - Global Markets Today While US Slept

U.S. markets up on trade deals and rate cut hopes, but concerns persist. Mixed economic data, Central bank expectations, and geopolitical risks affect performance. Asia and Europe markets mostly lower, commodities mixed, USD weak on trade uncertainty.

Is Elon's Empire Crumbling? - Ad

Jeff Brown - the legend who called Tesla and Nvidia early - says Elon is about to launch a $25T AI revolution. This isn't another chatbot. It's real-world AI that could 14X the impact of ChatGPT. But after July 23rd, it may be too late.

Netflix's Squid Game Finale Takes Over Seoul With Massive Parade, Star-Studded Fan Event

Netflix celebrated the finale of Squid Game with a parade and fan event in Seoul, featuring characters and emotional reflections from cast.

Quantum Stocks Surge And Stumble: Here's What Happened This Week

Quantum Computing announced a $200 million private placement, Microsoft's CEO said quantum computing could take scientific advancements to the next level and more from the week.

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd.

Kevin O'Leary Says 'You'll Never Be Free' If You Remain An Employee, But There's Actually Nothing Wrong With It: Here's Why

Shark Tank investor Kevin O'Leary says only 1 in 3 people have the determination to succeed as an entrepreneur and taste true freedom. He also praises Steve Jobs and Elon Musk for their high signal-to-noise ratio and work ethic.

What's inside Elon's building in Memphis will shock you - Ad

Inside Elon Musk's Memphis site lies a supercomputer built to power the world's first superhuman AI. It could make Elon a trillionaire - and new millionaires, too. With just $500, you could get in before the July 1st funding window closes.

Japan launches a climate change monitoring satellite on mainstay H2A rocket's last flight

TOKYO (AP) — Japan on Sunday launched a satellite to monitor greenhouse gas emissions using its mainstay rocket, which made its final flight before it is replaced by a new flagship designed to be more cost competitive in the global space market.

Wall Street Slumps, Dollar Jumps After Trump's Tariff Blitz: What's Moving Markets Monday?

President Donald Trump sent markets into a tailspin Monday after officially announcing sweeping 25% tariffs on all imports from Japan and South Korea, starting Aug. 1. The new tariffs apply to all goods from the two Asian economies and are in addition to any existing sector-specific duties.

Tariff-Driven Cash Payouts, Right Off Your Smart Phone? - Ad

The U.S. Treasury has raked in $15B from Trump's tariffs - and now, thanks to Title 15, you could pocket $100-$1,000 upfront payouts yourself. No stocks needed. Just use your phone and my #1 income strategy to start collecting now.

Elon Musk Says 'Clear Path' To Restoring Hearing With Neuralink, But The Deaf Community Want To Have Their 'Say'

Elon Musk's Neuralink faces backlash from the deaf community after proposing brain implant technology to restore hearing, with deaf adults calling for inclusion in the research process.

Elon's Greatest Invention... Hidden in South Memphis? - Ad

In South Memphis, I uncovered what could be Elon Musk's biggest invention yet. It's so secretive, rivals are flying drones to spy on it. If you're serious about investing in AI, now's the time to see what's really going on inside those walls.

Embed-chart-July Fourth-Pool Party Prices, ADVISORY

JULY FOURTH-POOL PARTY PRICES — chart. A market research company’s preliminary data shows that getting all the gear needed to host a pool party costs less than it has in years. This chart is current as of 07, 03, 2025 and will not update. Source: Numerator

Home Depot's $5.5B Deal Expands Its Reach To Thousands Of Job Sites

Analyst maintains Buy rating on Home Depot with $450 price target, noting plans for subsidiary SRS Distribution to acquire GMS for $4.3B.

Back This Medical AI Tech - Ad

You don't often find healthcare tech company valued at $4M. HeartSciences is an exception. With $75M invested, including R&D, clinical trials, and product development, their patented AI software is approaching FDA submission, a potential major inflection point.

How to manage ADHD at work and turn it into a strength

NEW YORK (AP) — Jeremy Didier had taken her son to a psychologist for a when she spotted an article about women with the condition. As she read it in the waiting room, she thought to herself: They're describing me.

650% Later, Rocket Lab CEO Isn't One Bit Worried

Rocket Lab CEO Peter Beck highlights strong demand for launches from both commercial and government customers.

A 64% Dividend From Gold? - Ad

Gold is soaring. But here's what no one's talking about: a way to earn a 64% dividend-paid in real cash every 30 days. No trading. No risky mining stocks. Just one simple move in your brokerage account... and you could start collecting monthly income almost instantly.

Lisa Murkowski Defends Alaska Carveouts As Elizabeth Warren, Bernie Sanders And Rand Paul Condemn Trump's 'Big Beautiful' Bill: 'Not Good Enough For The Rest Of Our Nation'

Senators across party lines are fiercely divided over Donald Trump's $3.3 trillion "Big Beautiful Bill," which narrowly passed the Senate and now heads to the House amid concerns over debt, tax cuts, and social program rollbacks.

What to Stream: Ryan Coogler’s 'Sinners,' a Kesha album, 'SharkFest' and John Cena with Idris Elba

Kesha enjoying her freedom on her first new album since she left her old label and Ryan Coogler’s guts-spilling vampire film “Sinners,” are some of the new television, films, music and games near you.

FDA Submission Expected This Summer - Invest Before It Happens - Ad

This company is making heart disease easier to detect with AI. Their tech has officially been designated a "Breakthrough" by the FDA. You now have an opportunity to get in at a potential inflection point.

Trending Now

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright trendadvisor.net
Privacy Policy | Terms of Service